STERIS director granted options and RSUs

STERIS plc director Nirav R. Shah reported equity awards consisting of stock options and restricted stock units.

Rhea-AI Filing Summary

STERIS plc director Nirav R. Shah reported equity awards consisting of stock options and restricted stock units. On 2026-08-10, he received 1,506 nonqualified stock options to purchase STERIS ordinary shares at an exercise price of $238.91 per share; these options are fully vested and exercisable immediately, and expire on 2036-08-10. On the same date, he also received 512 Career Restricted Stock Units, each representing one ordinary share to be delivered six months after his Board service ends; these RSUs are fully vested immediately. Following the RSU grant, his directly held equity related to these units totals 7,015 shares.

Insider Trade Summary

Grant/Award: 2,018 shares

Grant/Award 2 txns

Insider Shah Nirav R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Option (right to buy) F1	1,506	$0.00	$0.00
Grant/Award	Career Restricted Stock Units F2, F3	512	$0.00	$0.00

Holdings After Transaction: Director Stock Option (right to buy) — 1,506 contracts (Direct); Career Restricted Stock Units — 7,015 contracts (Direct)

Footnotes (3)

1. F1. These nonqualified stock options are fully vested and are exercisable immediately.
2. F2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
3. F3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Key Figures

Nonqualified stock options granted: 1,506 shares Option exercise price: $238.91 per share Option expiration date: 2036-08-10 +3 more

6 metrics

Nonqualified stock options granted 1,506 shares Director stock option grant on 2026-08-10

Option exercise price $238.91 per share Exercise price for 1,506 nonqualified stock options

Option expiration date 2036-08-10 Expiration of director stock options granted 2026-08-10

Career RSUs granted 512 units Career Restricted Stock Units awarded on 2026-08-10

Shares following RSU transaction 7,015 shares Total reported following Career RSU grant

Option-to-share ratio 1,506 underlying shares Each option relates to one STERIS ordinary share

Key Terms

Nonqualified stock options, Career Restricted Stock Units, exercise price

3 terms

Nonqualified stock options financial

"These nonqualified stock options are fully vested and are exercisable immediately."

A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.

Career Restricted Stock Units financial

"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"

exercise price financial

"conversion_or_exercise_price": "238.9100""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did STERIS (STE) director Nirav R. Shah receive on 2026-08-10?

Nirav R. Shah received 1,506 fully vested nonqualified stock options with a $238.91 exercise price and 512 fully vested Career Restricted Stock Units, each representing one STERIS ordinary share delivered after his Board service ends.

What is the exercise price and term of Nirav R. Shah’s new STERIS (STE) stock options?

The granted stock options have an exercise price of $238.91 per share and are fully vested and exercisable immediately. They carry an expiration date of 2036-08-10, providing a long-dated window to exercise into STERIS ordinary shares.

How do the Career Restricted Stock Units for STERIS (STE) director Nirav R. Shah settle?

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share. They are fully vested immediately but will be settled in shares six months after the cessation of Nirav R. Shah’s Board service with STERIS.

How many STERIS (STE) shares does Nirav R. Shah hold after the reported RSU grant?

After the 512 Career Restricted Stock Units were granted, the reported total directly related to these units is 7,015 shares. This figure reflects his position following the 2026-08-10 RSU award transaction disclosed in the Form 4.

Are Nirav R. Shah’s new STERIS (STE) stock options and RSUs immediately vested?

Yes. The 1,506 nonqualified stock options are reported as fully vested and exercisable immediately. The 512 Career Restricted Stock Units are also fully vested immediately, though settlement occurs months after his Board service ends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:33 PM Accepted by SEC EDGAR 08/12/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Nirav R

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$238.91	08/10/2026		A		1,506		(1)	08/10/2036	Ordinary Shares	1,506	$0	1,506	D
Career Restricted Stock Units	(2)	08/10/2026		A		512		(3)	(3)	Ordinary Shares	512	$0	7,015	D

Explanation of Responses:

1. These nonqualified stock options are fully vested and are exercisable immediately.

2. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

3. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)